PASCOLIZUMAB
UNII N1IOA09R6A

Substance Identification & Data

This profile provides standardized clinical and technical data for Pascolizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N1IOA09R6A.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 331243-22-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

N1IOA09R6A

CAS Registry Number

331243-22-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PASCOLIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C88618

National Cancer Institute reference terminology for clinical and research data.

INN ID

8227

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NN-39

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pascolizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PASCOLIZUMAB

Common Names & Synonyms

ANTI-IL-4 ANTIBODY

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 4) (HUMAN-MOUSE MONOCLONAL SB-240683 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL SB-240683 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 4) (HUMAN-MOUSE MONOCLONAL SB-240683 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL SB-240683 .KAPPA.-CHAIN, DIMER

PASCOLIZUMAB [INN]

PASCOLIZUMAB [USAN]

PASCOLIZUMAB [WHO-DD]